Gestational hypertension and the developmental origins of cardiac hypertrophy and diastolic dysfunction

被引:0
作者
David W. J. Armstrong
M. Yat Tse
Philip G. Wong
Nicole M. Ventura
Jalna A. Meens
Amer M. Johri
Murray F. Matangi
Stephen C. Pang
机构
[1] Queen’s University,Department of Biomedical and Molecular Sciences
[2] The Kingston Heart Clinic,Division of Cardiology
[3] Queen’s University and Kingston General Hospital,undefined
来源
Molecular and Cellular Biochemistry | 2014年 / 391卷
关键词
Developmental origins of health and disease; Diastolic dysfunction; Gestational hypertension; Gene expression;
D O I
暂无
中图分类号
学科分类号
摘要
The developmental origins of health and disease refer to the theory that adverse maternal environments influence fetal development and the risk of cardiovascular disease in adulthood. We used the chronically hypertensive atrial natriuretic peptide knockout (ANP−/−) mouse as a model of gestational hypertension, and attempted to determine the effect of gestational hypertension on left ventricular (LV) structure and function in adult offspring. We crossed normotensive ANP+/+ females with ANP−/− males (yielding ANP+/−WT offspring) and hypertensive ANP−/− females with ANP+/+ males (yielding ANP+/−KO offspring). Cardiac gene expression was measured using real-time quantitative PCR. Cardiac function was assessed using echocardiography. Daily injections of isoproterenol (ISO) were used to induce cardiac stress. Collagen deposition was assessed using picrosirius red staining. All mice were 10 weeks of age. Gestational hypertension resulted in significant LV hypertrophy in offspring, with no change in LV function. Treatment with ISO resulted in significant LV diastolic dysfunction with a restrictive filling pattern (increased E/A ratio and E/e′) and interstitial myocardial fibrosis only in ANP+/−KO and not ANP+/−WT offspring. Gestational hypertension programs adverse LV structural and functional remodeling in offspring. These data suggest that adverse maternal environments may increase the risk of heart failure in offspring later in life.
引用
收藏
页码:201 / 209
页数:8
相关论文
共 50 条
  • [31] Cystatin C and cardiac hypertrophy in primary hypertension
    Prats, Merche
    Font, Ramon
    Bardaji, Alfredo
    Gutierrez, Cristina
    Lalana, Marta
    Vilanova, Angels
    Martinez-Vea, Alberto
    BLOOD PRESSURE, 2010, 19 (01) : 20 - 25
  • [32] How to use MRI in cardiac disease with diastolic dysfunction?
    Cadour, Farah
    Cour, Adrien
    Senlis, Jules
    Rapacchi, Stanislas
    Chennoufi, Hajer
    Michelin, Paul
    Mcquade, Colin
    Demeyere, Matthieu
    Dacher, Jean-Nicolas
    BRITISH JOURNAL OF RADIOLOGY, 2024, : 1203 - 1213
  • [33] Cardiac Remodeling and Diastolic Dysfunction in Paroxysmal Atrial Fibrillation
    Noirclerc, Nathalie
    Huttin, Olivier
    de Chillou, Christian
    Selton-Suty, Christine
    Fillipetti, Laura
    Sellal, Jean Marc
    Bozec, Erwan
    Donal, Erwan
    Lamiral, Zohra
    Kobayashi, Masatake
    Ferreira, Joao Pedro
    Rossignol, Patrick
    Girerd, Nicolas
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (17)
  • [34] Diastolic dysfunction in pediatric cardiac patients: Evaluation and management
    Singh G.K.
    Holland M.R.
    Current Treatment Options in Cardiovascular Medicine, 2010, 12 (5) : 503 - 517
  • [35] Sacubitril/valsartan ameliorates cardiac hypertrophy and preserves diastolic function in cardiac pressure overload
    Norden, Einar Sjaastad
    Bendiksen, Bard Andre
    Andresen, Henriette
    Bergo, Kaja Knudsen
    Espe, Emil Knut
    Hasic, Almira
    Hauge-Iversen, Ida Marie
    Veras, Ioanni
    Hussain, Rizwan I.
    Sjaastad, Ivar
    Christensen, Geir
    Cataliotti, Alessandro
    ESC HEART FAILURE, 2021, 8 (02): : 918 - 927
  • [36] Ventricular-Arterial Uncoupling and Hypertension Mediated Diastolic Dysfunction
    Daniel Piskorz
    Luis Keller
    Luciano Citta
    Lucrecia Mata
    Norberto Citta
    Laureano Bongarzoni
    Paula Citta
    High Blood Pressure & Cardiovascular Prevention, 2022, 29 : 361 - 366
  • [37] Diastolic dysfunction in hypertension: a comprehensive review of pathophysiology, diagnosis, and treatment
    Ottosen, Camilla Ikast
    Nadruz, Wilson
    Inciardi, Riccardo M.
    Johansen, Niklas Dyrby
    Fudim, Marat
    Biering-Sorensen, Tor
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 2024, 25 (11) : 1525 - 1536
  • [38] Impaired glucose tolerance: A possible contributor to left ventricular hypertrophy and diastolic dysfunction
    Fujita, Masashi
    Asanuma, Hiroshi
    Kim, Jiyoong
    Liao, Yulin
    Hirata, Akio
    Tsukamoto, Osamu
    Minamino, Tetsuo
    Hori, Masatsugu
    Goto, Moritaka
    Node, Koichi
    Kitakaze, Masafumi
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2007, 118 (01) : 76 - 80
  • [39] N-acetylcysteine reverses diastolic dysfunction and hypertrophy in familial hypertrophic cardiomyopathy
    Wilder, Tanganyika
    Ryba, David M.
    Wieczorek, David F.
    Wolska, Beata M.
    Solaro, R. John
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2015, 309 (10): : H1720 - H1730
  • [40] Diastolic Dysfunction: Association with Hypertension and Potential Target for Antihypertensive Therapy
    Ogunyankin K.O.
    Current Cardiovascular Risk Reports, 2010, 4 (4) : 256 - 263